BioCryst (BCRX): Margin operasi

Logo korporat perusahaan BioCryst (BCRX)

BioCryst maintains its leadership in the orphan disease segment by investing in innovative complement inhibitors. The company is currently scaling global supplies of Orladeyo to achieve operational break-even. The operating margin spread illustrates this recovery in profitability, where 42.50 represents the current level of the metric. The brand's highest authority among patients with hereditary angioedema solidifies its status as a reliable pioneer in therapy.

BioCryst Pharmaceuticals, Inc. (BCRX): Tingkat bathi operasi saka 04.07.2022 nganti 19.11.2026

BCRX (BioCryst Pharmaceuticals): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Barang utama biocryst.com

Institutional capital evaluates BioCryst (BCRX) through the lens of its business model's sustainability. The operating profit margin reflects the share of profit from core operations in revenue before taxes and interest payments. This indicator measures real production efficiency, excluding accounting adjustments. For BioCryst, high margins confirm the commercial success of oral medications displacing injections. The stable trend on the chart guarantees the asset's fundamental reliability.

Pesaing wigati

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|Rentabilitas dodolan operasi Vera Therapeutics Inc VERA|Margin dodolan operasi DNTH (Dianthus Pharma)|Rentabilitas kegiatan operasi Pharvaris N.V.|AbCellera Biologics Inc - Margin dodolan operasi|Tourmaline Bio (TRML) - Rentabilitas dodolan operasi|PGEN - Rentabilitas operasi|Tingkat bathi operasi PHAR (Pharming Group NV)|NKTR: Margin operasi|Upstream Bio Corp - Tingkat bathi operasi|Rentabilitas operasi Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com